Skyepharma (SKP)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

49.13p
   
  • Change Today:
    -3.13p
  • 52 Week High: 101.50p
  • 52 Week Low: 43.50p
  • Currency: UK Pounds
  • Shares Issued: 46.13m
  • Volume: 109,527
  • Market Cap: £22.66m
  • RiskGrade: 236
  • Beta: 0.28

Skyepharma Overview

Skyepharma is a drug research and development company with a leading drug deliveries technology business, specialising in oral, topical, inhalable and injectable delivery systems.

1 Day Chart (23-05-2013)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 34.3% -4.3%
ROCE 53.7%  
Latest F'cast
P/E 44.7 n/a
PEG n/a n/a
Pr/Revenue 0.5 0.4
Pr/Book n/a  
Latest F'cast
Revenue -9.6% 13.3%
PBT n/a n/a
EPS -42.1% n/a
DPS n/a n/a

Skyepharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 62.20 (28.10) (1.70)p n/a n/a n/a n/a 0.0%
31-Dec-09 55.90 (0.90) (6.00)p n/a n/a n/a n/a 0.0%
31-Dec-10 58.10 6.50 29.60p 1.1 n/a n/a n/a 0.0%
31-Dec-11 55.20 (1.00) 1.90p 18.8 n/a -94% n/a 0.0%
31-Dec-12 49.90 (10.40) 1.10p 65.0 n/a -42% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Skyepharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 56.55 (2.45) (6.85)p n/a n/a n/a n/a 0.0%
31-Dec-14 69.50 3.70 4.10p 12.0 n/a n/a n/a 0.0%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

Skyepharma Company Announcements

Holding(s) in Company 21-May-2013 16:49 RNS
Holding(s) in Company 21-May-2013 13:52 RNS
Holding(s) in Company 21-May-2013 10:13 RNS

Skyepharma ShareCast News

SkyePharma on target for full year 15-Oct-2012 ShareCast
Small caps round-up: Infrastructure India, SkyeP... 23-Aug-2012 ShareCast
Small caps round-up: HaiKe Chemical, Mobile Torn... 17-Jul-2012 ShareCast

Skyepharma Top Newspaper Links

Skyepharma's asthma delivery system could be a $... 12-Jan-2009 The Independent
Skyepharma eyes debt swap 13-Jul-2008 Sunday Telegraph
Skyepharma hit by sell-off after collapse of ref... 09-Jul-2008 The Independent

Latest Skyepharma Director Deals

Traded Action Notifier PriceAmountValue
29-Apr-13 Transfer From Peter Grant 0.000p 278 £0.00
29-Apr-13 Buy Peter Grant 45.00p 278 £125.10
28-Mar-13 Transfer From Peter Grant 0.000p 250 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Skyepharma Market Data

Currency UK Pounds
Share Price 49.13p
Change Today -3.13p
% Change -5.98 %
52 Week High 101.50p
52 Week Low 43.50p
Volume 109,527
Shares Issued 46.13m
Market Cap £22.66m
Beta 0.28
RiskGrade 236

Skyepharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.88% below the market average37.88% below the market average37.88% below the market average37.88% below the market average37.88% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
33.81% below the market average33.81% below the market average33.81% below the market average33.81% below the market average33.81% below the market average
44% below the sector average44% below the sector average44% below the sector average44% below the sector average44% below the sector average
Income Not Available
Growth
88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average
89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average

Skyepharma Dividends

No dividends found

Trades for 23-May-2013

Time Volume / Share Price
16:34 55,000 @ 54.00p
12:47 2,000 @ 51.75p
12:19 5,000 @ 50.00p
12:18 11,404 @ 49.12p
10:56 1,200 @ 48.98p

Skyepharma Key Personnel

CEO Peter Grant

Top of Page